Mertiva AB operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mertiva AB with three other
miscellaneous service companies in Europe:
sales of 156,940.00 Norwegian Kroner [US$19,027.41 ]
Quantum Genomics SA
(17,400.00 Euro [US$18,933.64 ]
based in France
(17,040.00 Euro [US$18,541.91 ]
of which 100%
was Pharmaceutical Products).
Sales fell dramatically in 2013:
During the year ended December of 2013, sales at
Mertiva AB were SEK 170,000.00 (US$19.06 thousand).
decrease of 84.2%
versus 2012, when the company's sales were SEK 1.08 million.